Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
Thomas B AlexanderEtan OrgelPublished in: Current oncology reports (2021)
Recent collaborative efforts have made progress in understanding the genomic landscape and optimal therapy for MPAL. The preponderance of retrospective data supports beginning therapy with ALL directed regimens. Differences in prognosis for adult and children with MPAL have led to divergent approaches for therapy intensity, including use of stem cell transplantation consolidation. MPAL remains a challenging leukemia to understand, research, and treat due to low incidence, shifting and subjective approaches to classification, and innate biological heterogeneity. Ongoing research hopes to surmount these obstacles through prospective studies within large cooperative groups to provide new insight into targetable biology and further refine optimal therapy.
Keyphrases
- stem cell transplantation
- high dose
- immune response
- machine learning
- single cell
- young adults
- quality improvement
- acute myeloid leukemia
- bone marrow
- stem cells
- risk factors
- cross sectional
- gene expression
- dna methylation
- depressive symptoms
- physical activity
- high intensity
- artificial intelligence
- genome wide
- replacement therapy